NICE backs GSK’s Zejula in advanced ovarian cancer
Zejula has been recommended for use in newly diagnosed ovarian cancer patients - News - PharmaTimes
by Lucy Parsons
www.pharmatimes.com/news/nice_backs_gsks_zejlua_in_advanced_ovarian_cancer_1361315